Browse > Article

A Treatment Outcomes and Prognostic Factors of Malignant Submandibular Gland Tumor  

Lim Chi-Young (Department of Surgery, Yonsei University College of Medicine)
Nam Kee-Hyun (Department of Surgery, Yonsei University College of Medicine)
Lee Jan-Dee (Department of Surgery, Yonsei University College of Medicine)
Chang Hang-Seok (Department of Surgery, Yonsei University College of Medicine)
Chung Woong-Youn (Department of Surgery, Yonsei University College of Medicine)
Cha In-Ho (Department of Oral and Maxillofacial Surgery, Yonsei University College of Medicine)
Lee Chang-Geol (Department of Radiation Oncology, Yonsei University College of Medicine)
Choi Eun-Chan (Department of Otorhinolaryngology, Yonsei University College of Medicine)
Park Cheong-Soo (Department of Surgery, Yonsei University College of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.21, no.2, 2005 , pp. 201-207 More about this Journal
Abstract
Purpose: Submandibular gland tumor is rare, less than 6% of head and neck tumor. The purpose of this article is to analysis the clinical experience and treatment outcomes of malignant submandibular gland tumor, suggesting a guideline of management. Methods: We retrospectively evaluated 26 patients who underwent operation for malignant submandibular gland tumor at Severence hospital between 1986 and 2004. Statistical analysis was performed by Kaplan-Meier method, log rank test, Chi-square test, Fisher's exact test using SPSS v12.0 for Windows. Results: They consisted of 18 males and 8 females whose median age was 47 years(range: 20-71). 10 cases of adenocystic carcinoma, 8 cases of carcinoma ex pleomorphic adenoma, 4 cases of mucoepidermoid carcinoma, 1 case each for acinic cell carcinoma, undifferentiated carcinoma, adeno carcinoma, epithelioid hemangioendothelioma. Sialoadenectomy only was performed in 10 cases(36.5%) and sialoadenectomy with neck node dissection was performed in 16 cases(63.5%). Adjuvant radiotherapy was done in 22 cases(84.6%). 10 year disease free survival rate for malignant submandibular gland tumor was 63.1 % and 10 year overall survival rate for malignant submandibular gland tumor was 70.1%. In univariate analysis, prognostic factors affecting recurrence of malignant submandibular gland tumor was initially papable lateral neck node in physical examination and metastasis of lateral neck node in pathologic confirmation. The prognostic factors affecting survival of malignant submandibular gland tumor was tumor size, TNM stage, recurrence and type of recurrence. Conclusion: In this study, prognostic factors affecting recurrence of malignant submandibular gland tumor was initially papable lateral neck node in physical examination and metastasis of lateral neck node in pathologic confirmation. The prognostic factors affecting survival of malignant submandibular gland tumor was tumor size, TNM stage, recurrence and type of recurrence. To prevent recurrence and to improve survival, early diagnosis and aggressive surgery must be considered.
Keywords
Malignant submandibular gland tumor; Treatment outcomes; Prognostic factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Pinkston JA, Cole P. Incidence rates of salivary gland tumors: Results from a population-based study. Otolaryngol Head Neck Surg. 1999;120:834
2 Weber RS, Byers RM, Petit B. Submandibular gland tumors. Adverse histologic factors and therapeutic implications. Arch Otolaryngol Head Neck Surg. 1990;116:1055   DOI   ScienceOn
3 Kaneda T, Minami M, Ozawa K. MR of the submandibular gland: Normal and pathologic states. AJNR Am J Neuroradiol. 1996;17:1575
4 Conley J, Casler JD. Adenoid cystic cancer of the head and neck. Stuttgart: George Thieme Verlag, 1991
5 Bradley PJ. Distant metastases from salivary glands cancer. ORL J Otorhinolaryngol Related Spec. 2001;63:233   DOI   ScienceOn
6 Spitz MR, Batsakis JG. Major salivary gland carcinoma. Discriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110:45-49   DOI
7 Bradley PJ. Submandibular gland and minor salivary gland neoplasms. Curr Opin Otolaryngol Head Neck Surg. 1999;7-72-78   DOI   ScienceOn
8 Afify SE, Maynard JD. Carcinoma of the major salivary glands. Ann R Coil Surg Eng. 1992;74:186-191
9 Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands. Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998; 82:1217-1224   DOI   PUBMED   ScienceOn
10 Ellis GL, Auclair PL. Tumors of the salivary glands. Washington. DC: Armed Forces Institute of Pathology, 1996
11 Batsakis JG, Luna MA. Undifferentiated carcinomas of salivary glands. Ann Otol Rhinol Laryngol. 1991;100:82-84   DOI
12 Camilleri IG, Malata CM, McLean NR, Kelly CG. Malignant tumors of the submandibular salivary gland: A 15-year review. Br J Plast Surg. 1998;51:181   DOI   ScienceOn
13 Armstrong JG, Harrison LB, Spiro RH, Fasse DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990; 116:290-293   DOI   ScienceOn
14 Spiro RH, Huvos AG, Berk R, Strong EW. Mucoepidermoid carcinoma of salivary gland origin. Am J Surg. 1978;136:461-468   DOI   ScienceOn
15 Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer. 1983;52:542-549   DOI   PUBMED   ScienceOn
16 Spiro RH. Salivary neoplasm: overviews of a 35 years experience with 2807 patients. Head Neck Surg. 1986;8:177-184   DOI   PUBMED   ScienceOn
17 Green FL, Page DL, Fleming ID. AJCC cancer staging manual. 6th ed. New York: Springer, 2002:131-138
18 Shim SS, Oh KK, Lee YS, Han YC, Chu MJ. A clinical study on salivary gland tumors. Korean J Otolaryngol. 1990;33 (2);329-338
19 Wahlberg P, Anderson H, BiOrklund A, MOller T, Perfekt R. Carcinoma of the parotid and submandibular glands: A study of survival in 2465 patients. Oral Oncology. 2002;38:706-713   DOI   ScienceOn
20 Boccato P, Altavilla G, Blandamura S. Fine needle aspiration biopsy of salivary gland lesions: A reappraisal of pitfalls and problems: Acta Cytol. 1998;42:888   DOI   ScienceOn
21 Babb MJ, Rasgon BM, Cruz RM, Rumore GJ. Submandibular gland squamous metaplasia mimicking recurrent squamous cell carcinoma. Diagnostic dilemma. Arch Otolaryngol Head Neck Surg.2002;128:1201-1203   DOI
22 Storey MR, Garden AS, Morrison WH, Eicher SA, Schechter NR, Ang KK. Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys. 2001; 51:952-958   DOI   ScienceOn
23 Issing PR, Hemmanouil I, Wilkens L, Karstens H, Lenarz T. Long term results in adenoid cystic carcinoma. Loryngorhinootologie. 2002;81:98-105   DOI   ScienceOn
24 Oh KK, Lee GH, Choo MJ, Shim YS. Benign mixed tumor of the salivary gland LA clinical study. Korean J Otolarygol. 1992; 35 (5):632-639
25 Brandwein MS, Ivanov K, Wallace DI. Mucoepidermoid carcinoma: A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25:835   DOI   ScienceOn
26 Spiro RH, Huvos AG, Strong EW. Malignant mixed tumors of salivary origin. A clinicopathologic study of 146 cases. Cancer. 1977;39:388-396   DOI   PUBMED   ScienceOn
27 Castro EB, Huvos AG, Strong EW, Foote FW. Tumors of thew major salivary glands in children. Cancer. 1972;29:312-317   DOI   PUBMED   ScienceOn
28 Pyper PC, Beverland DE, Bell DM. Tumors of the submandibular gland. J R Coll Surg Edinb. 1987;32:233-236
29 Renehan A, Gleave EN, Hancock BD. Long-term follow-up of over 1000patients with salivary gland tumours treated in a single centre. Br J Surg. 1996;83:1750
30 Conley J, Myers E, Cole R. Analysis of 115 patients with tumors of the submandibular gland. Ann Otol Rhinol Laryngol. 1972; 81:323-330   DOI